Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

References for PMC Articles for PubMed (Select 20837780)

1.

HIV-1-specific antibody responses during acute and chronic HIV-1 infection.

Tomaras GD, Haynes BF.

Curr Opin HIV AIDS. 2009 Sep;4(5):373-9. doi: 10.1097/COH.0b013e32832f00c0. Review.

2.

Loss of HIV-specific memory B-cells as a potential mechanism for the dysfunction of the humoral immune response against HIV.

Bussmann BM, Reiche S, Bieniek B, Krznaric I, Ackermann F, Jassoy C.

Virology. 2010 Feb 5;397(1):7-13. doi: 10.1016/j.virol.2009.11.003. Epub 2009 Dec 4.

3.

Restoration of the antibody response upon rabies vaccination in HIV-infected patients treated with HAART.

Gelinck LB, Jol-van der Zijde CM, Jansen-Hoogendijk AM, Brinkman DM, van Dissel JT, van Tol MJ, Kroon FP.

AIDS. 2009 Nov 27;23(18):2451-8. doi: 10.1097/QAD.0b013e328331a43b.

PMID:
19741483
4.

Selective expansion of HIV-1 envelope glycoprotein-specific B cell subsets recognizing distinct structural elements following immunization.

Dosenovic P, Chakrabarti B, Soldemo M, Douagi I, Forsell MN, Li Y, Phogat A, Paulie S, Hoxie J, Wyatt RT, Karlsson Hedestam GB.

J Immunol. 2009 Sep 1;183(5):3373-82. doi: 10.4049/jimmunol.0900407.

5.

Memory B cells: effectors of long-lived immune responses.

Tangye SG, Tarlinton DM.

Eur J Immunol. 2009 Aug;39(8):2065-75. doi: 10.1002/eji.200939531. Review. Erratum in: Eur J Immunol. 2010 Jan;40(1):302.

PMID:
19637202
6.

HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infection.

Bonsignori M, Moody MA, Parks RJ, Holl TM, Kelsoe G, Hicks CB, Vandergrift N, Tomaras GD, Haynes BF.

J Immunol. 2009 Aug 15;183(4):2708-17. doi: 10.4049/jimmunol.0901068. Epub 2009 Jul 22.

7.

Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1.

Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, Kulkarni S, Wen TF, Lindsay RJ, Orellana L, Mildvan D, Bazner S, Streeck H, Alter G, Lifson JD, Carrington M, Bosch RJ, Robbins GK, Altfeld M.

Nat Med. 2009 Aug;15(8):955-9. doi: 10.1038/nm.2004. Epub 2009 Jul 13.

8.

Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area.

Weiss GE, Crompton PD, Li S, Walsh LA, Moir S, Traore B, Kayentao K, Ongoiba A, Doumbo OK, Pierce SK.

J Immunol. 2009 Aug 1;183(3):2176-82. doi: 10.4049/jimmunol.0901297. Epub 2009 Jul 10.

9.

Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection.

Levesque MC, Moody MA, Hwang KK, Marshall DJ, Whitesides JF, Amos JD, Gurley TC, Allgood S, Haynes BB, Vandergrift NA, Plonk S, Parker DC, Cohen MS, Tomaras GD, Goepfert PA, Shaw GM, Schmitz JE, Eron JJ, Shaheen NJ, Hicks CB, Liao HX, Markowitz M, Kelsoe G, Margolis DM, Haynes BF.

PLoS Med. 2009 Jul 7;6(7):e1000107. doi: 10.1371/journal.pmed.1000107. Epub 2009 Jul 7.

10.

HIV-1 and influenza antibodies: seeing antigens in new ways.

Kwong PD, Wilson IA.

Nat Immunol. 2009 Jun;10(6):573-8. doi: 10.1038/ni.1746. Review.

11.

Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children.

Pensieroso S, Cagigi A, Palma P, Nilsson A, Capponi C, Freda E, Bernardi S, Thorstensson R, Chiodi F, Rossi P.

Proc Natl Acad Sci U S A. 2009 May 12;106(19):7939-44. doi: 10.1073/pnas.0901702106. Epub 2009 Apr 27.

12.

CD27(-) B-cells produce class switched and somatically hyper-mutated antibodies during chronic HIV-1 infection.

Cagigi A, Du L, Dang LV, Grutzmeier S, Atlas A, Chiodi F, Pan-Hammarström Q, Nilsson A.

PLoS One. 2009;4(5):e5427. doi: 10.1371/journal.pone.0005427. Epub 2009 May 1.

13.

B cells in HIV infection and disease.

Moir S, Fauci AS.

Nat Rev Immunol. 2009 Apr;9(4):235-45. doi: 10.1038/nri2524. Review.

14.

Influence of prior influenza vaccination on antibody and B-cell responses.

Sasaki S, He XS, Holmes TH, Dekker CL, Kemble GW, Arvin AM, Greenberg HB.

PLoS One. 2008 Aug 20;3(8):e2975. doi: 10.1371/journal.pone.0002975.

15.

Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals.

Moir S, Ho J, Malaspina A, Wang W, DiPoto AC, O'Shea MA, Roby G, Kottilil S, Arthos J, Proschan MA, Chun TW, Fauci AS.

J Exp Med. 2008 Aug 4;205(8):1797-805. doi: 10.1084/jem.20072683. Epub 2008 Jul 14.

16.

Plasma cell differentiation and survival.

Tarlinton D, Radbruch A, Hiepe F, Dörner T.

Curr Opin Immunol. 2008 Apr;20(2):162-9. doi: 10.1016/j.coi.2008.03.016. Epub 2008 May 2. Review.

PMID:
18456483
17.

Restoration of anti-tetanus toxoid responses in patients initiating highly active antiretroviral therapy with or without a boost immunization: an INITIO substudy.

Burton CT, Goodall RL, Samri A, Autran B, Kelleher AD, Poli G, Pantaleo G, Gotch FM, Imami N; INITIO Trial International Co-ordinating Committee.

Clin Exp Immunol. 2008 May;152(2):252-7. doi: 10.1111/j.1365-2249.2008.03611.x.

18.

Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease.

Moir S, Malaspina A, Ho J, Wang W, Dipoto AC, O'Shea MA, Roby G, Mican JM, Kottilil S, Chun TW, Proschan MA, Fauci AS.

J Infect Dis. 2008 Feb 15;197(4):572-9. doi: 10.1086/526789.

19.

The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus.

Karlsson Hedestam GB, Fouchier RA, Phogat S, Burton DR, Sodroski J, Wyatt RT.

Nat Rev Microbiol. 2008 Feb;6(2):143-55. doi: 10.1038/nrmicro1819. Review.

PMID:
18197170
20.

B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design.

Cagigi A, Nilsson A, De Milito A, Chiodi F.

Vaccine. 2008 Jun 6;26(24):3016-25. doi: 10.1016/j.vaccine.2007.11.063. Epub 2007 Dec 17. Review.

PMID:
18164520
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk